Development of Positive Psychotherapy for Smoking Cessation
Phase 2
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Smoking
Both
Smoking
Trial Information
Development of Positive Psychotherapy for Smoking Cessation
Inclusion Criteria:
- smoke at least 5 cigarettes per day for longer than one year with no other ongoing
tobacco product use
- willing to use the transdermal nicotine patch
- report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking.
Exclusion Criteria:
- are currently experiencing psychotic symptoms, affective disorder (major depression,
dysthymia, or mania) or substance use disorder (other than nicotine dependence)
- taking prescribed psychotropic medication or receiving other forms of psychotherapy
- concomitantly using other pharmacotherapies for smoking cessation
- have any contraindications for use of the transdermal nicotine patch.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
7-day point prevalence smoking abstinence
Outcome Description:
Biochemically verified abstinence from smoking over the past 7 days
Outcome Time Frame:
8 weeks
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
NCI-156241-1
NCT ID:
NCT01451814
Start Date:
October 2011
Completion Date:
December 2013
Related Keywords:
- Smoking
- smoking cessation
- Smoking
Name | Location |
|---|---|
| Center for Alcohol and Addiction Studies, Brown University | Providence, Rhode Island 02912 |
